Page last updated: 2024-08-22

vidarabine and Leukemia, Prolymphocytic

vidarabine has been researched along with Leukemia, Prolymphocytic in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (55.56)18.2507
2000's5 (27.78)29.6817
2010's3 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergmann, L; Chow, KU; Cordes, HJ; Kim, SZ; Schlegelberger, B; Stilgenbauer, S; von Neuhoff, N; Wunderle, L1
Rossi, D1
Appelbaum, FR; Belch, A; Kolitz, JE; Larson, RA; Morrison, VA; Peterson, BL; Rai, KR; Solh, M; Tallman, MS1
Hirayama, Y; Kawano, Y; Kogawa, K; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Okamoto, T; Sato, T; Takayama, T; Watanabe, H1
Bulanov, AIu; Chernova, NG; Gretsov, EM; Kalinin, NN; Kravchenko, SK; Kremenetskaia, AM; Mar'in, DS; Petrova, VI; Semenova, EA; Valiev, TT; Vinogradova, IuE; Volkova, IaK; Vorob'ev, AI1
Robak, P; Robak, T1
Lundberg, JH; Tefferi, A; Weitz, JJ; Witzig, TE1
Doorduijn, JK; Michiels, JJ1
Bendandi, M; Tabanelli, M; Tura, S; Zinzani, PL1
Cannon, LM; Garfinkel, H; Pezzimenti, J; Rhodes, R; Spilove, L1
Bowen, AL; Catovsky, D; Dyer, MJ; Emmett, E; Matutes, E; Zomas, A1
Crollo, R; D'Oronzio, L; Dambra, P; Dell'Osso, A; Grande, M; Lasaracina, E; Loria, MP; Lucivero, G1
Andrieu, V; Carbon, C; Couvelard, A; Encaoua, R; Grange, MJ1
Catovsky, D; Dearden, CE; Matutes, E1
Ayres, M; Du, M; Gandhi, V; Hodge, JP; Keating, MJ; O'Brien, S; Plunkett, W; Ramakrishna, P; Rodriguez, CO; Rosner, GL; Weller, S1
Marlton, P; McCarthy, C; Taylor, K1
Sporn, JR1
Beran, M; Childs, C; Huh, Y; Kantarjian, HM; Keating, MJ; Koller, C; O'Brien, S; Schachner, J1

Reviews

1 review(s) available for vidarabine and Leukemia, Prolymphocytic

ArticleYear
Current treatment options in prolymphocytic leukemia.
    Medical science monitor : international medical journal of experimental and clinical research, 2007, Volume: 13, Issue:4

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Drug Therapy; Humans; Leukemia, Prolymphocytic; Pentostatin; Purine Nucleosides; Rituximab; Splenectomy; Stem Cell Transplantation; Vidarabine

2007

Trials

3 trial(s) available for vidarabine and Leukemia, Prolymphocytic

ArticleYear
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
    European journal of haematology, 2011, Volume: 87, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Female; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Middle Aged; Prospective Studies; Rituximab; Vidarabine

2011
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-15, Volume: 19, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Arabinonucleotides; Biomarkers; Female; Guanosine Triphosphate; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Prolymphocytic; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Treatment Outcome; Vidarabine

2001
Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
    The American journal of medicine, 1991, Volume: 90, Issue:2

    Topics: Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Female; Humans; Immunoglobulin M; Karyotyping; Leukemia, Prolymphocytic; Male; Middle Aged; Prednisone; Remission Induction; Vidarabine

1991

Other Studies

14 other study(ies) available for vidarabine and Leukemia, Prolymphocytic

ArticleYear
Richter syndrome and fludarabine: a controversial relationship.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:2

    Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Vidarabine

2013
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
    Leukemia & lymphoma, 2013, Volume: 54, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Vidarabine

2013
Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
    International journal of clinical oncology, 2003, Volume: 8, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Drug Resistance, Neoplasm; Humans; Intestinal Polyposis; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Prednisone; Transplantation, Homologous; Treatment Outcome; Vidarabine; Vincristine

2003
[Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
    Terapevticheskii arkhiv, 2006, Volume: 78, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Middle Aged; Mitoxantrone; Remission Induction; Vidarabine

2006
Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2

    Topics: 2-Chloroadenosine; Anemia; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Deoxyadenosines; Fatal Outcome; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Male; Methotrexate; Middle Aged; Neoplastic Stem Cells; Prednisone; Salvage Therapy; Vidarabine; Vincristine; Zidovudine

1994
Effectiveness of fludarabine in end-stage prolymphocytic leukemia.
    Leukemia, 1994, Volume: 8, Issue:8

    Topics: Aged; Anemia; Antigens, CD; Antineoplastic Agents; Blood Transfusion; Chlorambucil; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Neoplasm Staging; Splenectomy; Thrombocytopenia; Vidarabine

1994
Prolonged bone marrow aplasia of refractory prolymphocytoid variant of B-cell chronic lymphocytic leukemia related to fludarabine treatment.
    European journal of haematology, 1994, Volume: 53, Issue:1

    Topics: Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukopenia; Male; Middle Aged; Neutropenia; Vidarabine

1994
Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Connecticut medicine, 1993, Volume: 57, Issue:10

    Topics: Acute Disease; Aged; Antineoplastic Agents; Fatal Outcome; Female; Humans; Leukemia, Prolymphocytic; Tumor Lysis Syndrome; Vidarabine

1993
Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia.
    British journal of haematology, 1997, Volume: 96, Issue:3

    Topics: Administration, Cutaneous; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Recurrence; Vidarabine

1997
Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.
    European journal of histochemistry : EJH, 1997, Volume: 41 Suppl 2

    Topics: Aged; Antigens, CD; Antineoplastic Agents; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia, Plasma Cell; Leukemia, Prolymphocytic; Lymphocytes; Male; Phenotype; Vidarabine

1997
Leukemic pleural effusion in B-cell prolymphocytic leukemia.
    Hematology and cell therapy, 1998, Volume: 40, Issue:6

    Topics: Aged; Antibodies; Antigens, CD20; Antineoplastic Agents; Humans; Immunohistochemistry; Leukemia, B-Cell; Leukemia, Prolymphocytic; Male; Pleural Effusion, Malignant; Remission Induction; Tomography Scanners, X-Ray Computed; Vidarabine

1998
Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Seminars in oncology, 2000, Volume: 27, Issue:2 Suppl 5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia; Leukemia, B-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Pentostatin; Sezary Syndrome; Survival Rate; Vidarabine

2000
Fludarabine-induced cytogenetic remission in prolymphocytic leukemia.
    American journal of hematology, 1992, Volume: 40, Issue:1

    Topics: Aged; Chromosome Aberrations; Chromosome Disorders; Humans; Karyotyping; Leukemia, Prolymphocytic; Male; Vidarabine

1992
Sustained response of refractory prolymphocytic leukemia to fludarabine.
    Acta haematologica, 1991, Volume: 85, Issue:4

    Topics: Aged; Antimetabolites, Antineoplastic; Humans; Leukemia, Prolymphocytic; Leukocyte Count; Male; Remission Induction; Spleen; Vidarabine

1991